242 related articles for article (PubMed ID: 34638306)
1. Classifying Oligometastatic Non-Small Cell Lung Cancer.
Blumenthaler AN; Antonoff MB
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638306
[TBL] [Abstract][Full Text] [Related]
2. The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer.
Euhus CJ; Ripley TR; Medina CG
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626125
[TBL] [Abstract][Full Text] [Related]
3. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.
Rashdan S; Iyengar P; Minna JD; Gerber DE
Transl Lung Cancer Res; 2021 Jul; 10(7):3351-3368. PubMed ID: 34430372
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiotherapy in oligometastatic cancer.
Kennedy TAC; Corkum MT; Louie AV
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
[TBL] [Abstract][Full Text] [Related]
5. Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Santos PMG; Li X; Gomez DR
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010969
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
Mitchell KG; Farooqi A; Ludmir EB; Corsini EM; Sepesi B; Gomez DR; Antonoff MB;
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1497-1504.e2. PubMed ID: 32331820
[TBL] [Abstract][Full Text] [Related]
7. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.
Ni Y; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
J Cancer Res Clin Oncol; 2020 Jan; 146(1):197-203. PubMed ID: 31599340
[TBL] [Abstract][Full Text] [Related]
8. Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs.
Xu Q; Zhou F; Liu H; Jiang T; Li X; Xu Y; Zhou C
J Thorac Oncol; 2018 Sep; 13(9):1383-1392. PubMed ID: 29852232
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update.
Chen YH; Ho UC; Kuo LT
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267658
[TBL] [Abstract][Full Text] [Related]
10. Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
Schroeder SR; Leenders M; Iyengar P; de Ruysscher D
Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S184-S191. PubMed ID: 31673523
[TBL] [Abstract][Full Text] [Related]
11. The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review.
Berzenji L; Debaenst S; Hendriks JMH; Yogeswaran SK; Lauwers P; Van Schil PE
Transl Lung Cancer Res; 2021 Jul; 10(7):3409-3419. PubMed ID: 34430376
[TBL] [Abstract][Full Text] [Related]
12. Local ablative radiotherapy for oligometastatic non-small cell lung cancer.
Suh YG; Cho J
Radiat Oncol J; 2019 Sep; 37(3):149-155. PubMed ID: 31591862
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of local aggressive lung therapy versus systemic therapy in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis.
Zhang C; Ma N; Zhang Q; Zheng K; Sun C; Tang X; Li X; Zhao J
J Thorac Dis; 2021 Oct; 13(10):5899-5910. PubMed ID: 34795938
[TBL] [Abstract][Full Text] [Related]
14. The current state of oligometastatic and oligoprogressive non-small cell lung cancer.
Tumati V; Iyengar P
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2537-S2544. PubMed ID: 30206497
[TBL] [Abstract][Full Text] [Related]
15. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
[TBL] [Abstract][Full Text] [Related]
16. Surgical approach in oligometastatic non-small cell lung cancer.
Patrini D; Panagiotopoulos N; Bedetti B; Mitsos S; Crisci R; Solli P; Bertolaccini L; Scarci M
Ann Transl Med; 2018 Mar; 6(5):93. PubMed ID: 29666816
[TBL] [Abstract][Full Text] [Related]
17. Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
Giaj-Levra N; Giaj-Levra M; Durieux V; Novello S; Besse B; Hasan B; Hendriks LE; Levy A; Dingemans AC; Berghmans T;
J Thorac Oncol; 2019 Dec; 14(12):2053-2061. PubMed ID: 31195177
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.
Iyengar P; All S; Berry MF; Boike TP; Bradfield L; Dingemans AC; Feldman J; Gomez DR; Hesketh PJ; Jabbour SK; Jeter M; Josipovic M; Lievens Y; McDonald F; Perez BA; Ricardi U; Ruffini E; De Ruysscher D; Saeed H; Schneider BJ; Senan S; Widder J; Guckenberger M
Pract Radiat Oncol; 2023; 13(5):393-412. PubMed ID: 37294262
[TBL] [Abstract][Full Text] [Related]
19. Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
Peeters STH; Van Limbergen EJ; Hendriks LEL; De Ruysscher D
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925139
[TBL] [Abstract][Full Text] [Related]
20. Managing Patients With Oligometastatic Non-Small-Cell Lung Cancer.
Stephens SJ; Moravan MJ; Salama JK
J Oncol Pract; 2018 Jan; 14(1):23-31. PubMed ID: 29324212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]